cAMP analogs promote survival and neurite outgrowth in cultures of rat sympathetic and sensory neurons independently of nerve growth factor (neurotrophic agents/neuronal regeneration/neuronal differentiaion/8-(4-chlorophenylthio)-cAMP/8-bromo-cAMP) RUSSELL E. RYDEL* AND LLOYD A. GREENEt Department of Pharmacology, New York University School of Medicine, 550 First Avenue, New York, NY 10016 Communicated by Rodolfo R. Llinas, September 8, 1987 (received for review May 8, 1987) ABSTRACT Nerve growth factor (NGF) is a neurotrophic agent for sympathetic and embryonic sensory neurons both in vivoi and in vitro. We report here that the membrane-permeant cAMP analogs, 8-(4-chlorophenylthio)-cAMP and 8-bromocAMP, can replace NGF in promoting long-term survival and neurite outgrowth in cultures of rat neonatal sympathetic and embryonic sensory neurons. N'-substituted analogs, including the more commonly used N6,02'-dibutyryl-cAMP, are less efficacious. Additivity and switching experiments indicate that the cAMP analogs affect the same neuronal population as that maintained by NGF. However, unlike NGF, the cAMP analogs do not evoke somatic hypertrophy. Moreover, studies with sympathetic neurons reveal that the neurotrophic actions of the cAMP analogs, but not of NGF, are blocked by the axial diastereoisomer of adenosine 3',5'-phosphorothioate, a competitive cAMP antagonist. Thus, the mechanism by which cAMP analogs promote neuronal survival and differentiation appears to involve activation of cAMP-dependent protein kinases, whereas, in contrast, the same effects of NGF neither require nor are mediated by such a pathway. Furthermore, the different efficacies observed with N6-and C8-substituted cAMP analogs suggest that this neurotrophic pathway may involve differential activation of the regulatory subunits of cAMP-dependent protein kinases. The presence of this parallel, cAMP-responsive, neurotrophic pathway in at least two types of NGF-responsive neurons may be developmentally important and has the potential to be exploited for the treatment of injuries or diseases affecting these and possibly other nerve cells.
A wide variety of extracellular signals, both inside and outside the nervous system, produce many of their diverse responses by regulating the phosphorylation of specific proteins. In particular, protein phosphorylation has been implicated as a molecular mechanism by which extracellular signals regulate various intracellular functions in nervous tissue, including neuronal excitability, neurotransmitter biosynthesis and release, and also neuronal growth, differentiation, and morphology (reviewed in ref. 1) . One mechanism by which many extracellular signals regulate protein phosphorylation involves the synthesis of cAMP and subsequent activation of its target enzymes, the cAMP-dependent protein kinases (reviewed in ref. 2) . In vertebrate nervous tissue, the regulatory subunits of cAMP-dependent protein kinases appear to be the major, if not the only, proteins that bind and are activated by cAMP (3, 4) .
One of the best characterized mediators of nervous system development is the trophic polypeptide, nerve growth factor (NGF). NGF profoundly influences the differentiated state and maintenance of a variety of nerve cells, including sensory, sympathetic, and certain central nervous system neurons (5) (6) (7) (8) . In particular, previous studies have shown the inability of sympathetic and embryonic sensory neurons to survive in vivo (5, 9, 10) or in vitro (11, 12) in the absence of NGF. Although current knowledge of the molecular events orchestrating NGF's neurotrophic properties is limited, both transcription-independent and transcriptiondependent pathways appear to be involved in NGFpromoted neurite outgrowth and neuronal differentiation (reviewed in ref. 13) . In this regard, various groups (14) (15) (16) (17) (18) (19) (20) have reported that cAMP analogs and NGF have both synergistic and differential actions on NGF-responsive cells. cAMP analogs have been reported to modulate the phosphorylation of a similar group of proteins, as does NGF (14, 15) .
However, the effects of cAMP analogs and NGF on rat PC12 cell surface morphology (16) and neurite outgrowth from both PC12 cells (17) (18) (19) and embryonic chicken sensory ganglia (20) suggest divergent pathways of action.
To more fully understand the role of cAMP and phosphorylation in the mechanism of NGF's action, we exposed cultures of dissociated rat neonatal superior cervical ganglia and embryonic dorsal root ganglia to a variety of agents, including those that either mimic or elevate intracellular levels of cAMP. We report here that certain, but not all, permeant cAMP analogs can maintain survival of (and promote neurite outgrowth by) the same neuronal population as that maintained by NGF. Moreover, use of a competitive cAMP antagonist (19, (21) (22) (23) (24) (25) indicates that the actions of these analogs require activation of cAMP-dependent protein kinase(s), whereas, in contrast, NGF-promoted survival and neurite outgrowth neither require nor are mediated by way of cAMP.
A portion of these studies has previously appeared in abstract form (26) .
MATERIALS AND METHODS
Tissue Culture. Postnatal day 1-3 rat superior cervical ganglion cells were dissociated and plated at a density of 1 ganglion per 16-mm or 35-mm culture dish as previously described (27) . Embryonic day 15 rat dorsal root ganglion cells were dissociated and plated at a density of 8-11 ganglia per 35-mm culture dish as described by Salzer et al. (28) , except that 15% fetal bovine serum was used in place of human placental serum and chicken embryo extract. For most experiments, a laminin substrate (29) was utilized except where noted, when cultures were maintained on a collagen substrate (27) . Cultures were treated with either NGF (50 ng/ml) or the agent to be tested, and the culture medium was changed every other day. Cultures highly enriched for neuronal cells were obtained by treatment with 10 /1M cytosine arabinoside from the first to seventh day after plating (superior cervical ganglia cultures) or by continuous exposure to 10 AM fluorodeoxyuridine and 10 utM uridine (dorsal root ganglia cultures).
Determination (Fig. 1) . Two of the agents tested, CPT-cAMP and 8Br-cAMP, maintained neuronal survival and promoted neurite outgrowth to a similar extent as NGF (Figs. 1A and 2) for at least 1 month (Fig. 2H ). These effects of CPT-cAMP and 8Br-cAMP were dose-dependent and had maximal activities between 100 and 300 uM and 0.3 to 1.0 mM, respectively (Fig. 1B) was not due to general cytotoxic properties, since they did not interfere with (nor did they enhance) NGF-promoted neuronal survival or neurite outgrowth (not shown).
The survival requirement of rat sympathetic neurons appears to be highly selective for cAMP analogs and NGF. Treatment with 8-bromo-or dibutyryl-cGMP (0.01-2 mM), basic fibroblast growth factor (300 pM), insulin (200 nM), K+ (40 mM), or phorbol 12-myristate 13-acetate (4 nM-1 ,uM), an activator of protein kinase C, failed to maintain neuronal survival (not shown). In addition, these agents had no evident effect on NGF-promoted survival or neurite outgrowth (not shown). These concentrations of insulin, K+, and phorbol 12-myristate 13-acetate have been reported to promote survival and neurite outgrowth in cultures of chicken sympathetic neurons (32, 33) .
cAMP Analogs and NGF Affect the Same Population of Rat Sympathetic Neurons. Since the recovery of neurons in our culture system is less than the number initially plated (57-67% after 7 days), experiments were performed to determine if the same neuronal population responds both to NGF and to cAMP analogs. In one set of studies, 7-day-old cultures initiated in the presence of NGF were rinsed extensively and then were maintained for an additional 4 days in the presence of anti-NGF antiserum or anti-NGF antiserum plus CPT-cAMP. Removal of NGF resulted in the total loss of neuronal viability ( Fig. 2A) , whereas removal of NGF coupled with the addition of CPT-cAMP afforded maintenance of neuronal survival and neurite integrity (Fig. 2B) .
In another set of experiments, sympathetic neuron cultures were initiated in the presence of either NGF, CPTcAMP, or CPT-cAMP plus NGF. After 7 days, the cultures were extensively rinsed and then maintained for an additional week in the presence of either NGF, CPT-cAMP plus anti-NGF antiserum, CPT-cAMP plus NGF, or anti-NGF antiserum. The numbers of surviving neurons were determined at various times throughout the experiment (Fig. 3) . CPT-cAMP (B), or CPT-cAMP plus NGF (C) for 7 days. The neurons were rinsed extensively with NGF-free medium on day 7 (arrow) and then maintained for an additional 7 days in the presence of NGF (m in A and B), CPT-cAMP plus anti-NGF antiserum (CPT; A), CPT-cAMP plus NGF (CPT + NGF; m in C), or anti-NGF antiserum (CON, A). Cultures were also maintained without additives (--z--in A). Neuronal numbers were determined as in Fig. 1 . The values after 14 days are the average of counts from duplicate dishes; variation between the duplicates was 5-10%o. Comparable results were obtained in four additional, independent experiments. these conditions, neurites elicited by cAMP analogs were much more highly fasciculated and appeared to be less extensive than those elicited by NGF (Fig. 2 C and D) . However, when the neurons were plated on a laminin substrate, the rate of neurite formation and the extent of fasciculation were similar for both types of treatment; nevertheless, the density of outgrowth was consistently less in the presence of cAMP analogs (Fig. 2 E and F) . Furthermore, relative to their state at the time of plating, NGF produced a marked hypertrophy of neuronal cell bodies in cultures utilizing either substrate (Fig. 2 C , E, and G); in contrast, this never occurred with 8Br-cAMP or CPTcAMP, even in cultures maintained for one month (compare Fig. 2 D, F, and H) . However, addition of NGF to cultures maintained with cAMP analogs did produce somatic hypertrophy as well as enhancement in neurite density (not shown).
The (19, (21) (22) (23) (24) (25) . When assessed after 4 days of treatment, Rp-cAMP[S] had little or no effect on survival or neurite outgrowth in cultures initiated with NGF, but it almost completely blocked the survival-promoting effects of CPT-cAMP (Fig. 4) responses generated by the analogs and NGF. Unlike NGF, the cAMP analogs do not evoke somatic hypertrophy. In addition, neurite outgrowth on a collagen substrate is both delayed in its appearance and more highly fasciculated in the presence of cAMP analogs as compared to the outgrowth generated by NGF.
Our studies also demonstrate that CPT-cAMP promotes survival and neurite outgrowth by dissociated embryonic rat sensory neurons. These observations, coupled with reports that cAMP analogs affect cell survival (34) and neurite outgrowth (35, 36) in other neuronal populations, suggest that there may be a more general occurrence of cAMPmediated neurotrophic pathways.
The use of a variety of cAMP analogs has revealed differential effects of C-8-and N6-substituted cAMP derivatives. Thus, N6-substituted analogs are less efficacious than C-8-substituted analogs in promoting sympathetic neuron survival. This is consistent with reports that the N6-substituted analog Bt2cAMP is relatively ineffective in certain other systems known to be regulated by cAMP (25, 37, 38) . Conformation studies indicate that C-8-substituted analogs have a predominately syn configuration, whereas, in contrast, N6-substituted analogs display an anti conformation (39, 40) . These observations raise the possibility that the differential effects of the C-8-and N6-substituted analogs could arise from selective activation of specific forms of cAMP-dependent protein kinase. In support of this, various analogs apparently display selectivity of interaction with the two types (41) (42) (43) [or isoforms thereof (44)] of cAMPdependent protein kinase regulatory subunits RI and RI,. In addition, C-8-and N6-substituted analogs can display quite distinct specificities for interaction with the two intrachain cAMP binding sites found on RI and RI, (45, 46) . Moreover, several different agents that elevate intracellular cAMP levels have been reported to lead to selective activation of the RI and RI, isotypes (47) (48) (49) . Thus, if the neurotrophic actions of cAMP and its analogs do indeed require differential effects on the various forms of cAMP-dependent protein kinase, then the response of a given cell to an agent that elevates or mimics cAMP will be governed both by the types and distribution of cAMP-dependent protein kinase forms that it possesses and by the nature of the agent itself.
Whatever the source of differences in neurotrophic activity of the various analogs, since many previous studies on the role of cAMP in neuronal function have exclusively utilized Bt2cAMP, the present results suggest that future work should also include C-8-substituted derivatives.
The presence of a cAMP-mediated neurotrophic pathway parallel to that of NGF raises several intriguing possibilities.
For instance, the early differentiation of mammalian sympathetic neurons appears to occur independently of NGF (50, 51) . Our observations thus raise the possibility that such development may be mediated by way of a cAMP-dependent pathway. In addition, it has been reported (52) that the activity of the cAMP generating system in rat sympathetic neurons is directly proportional to neurite length. The establishment of extensive neuronal networks could thus account for the decreased NGF dependence that occurs with maturation of sympathetic neurons in vivo (53) and in vitro (54) . Such a mechanism could also explain the capacity of sympathetic neurons in long-term cultures to undergo NGFindependent neurite regeneration (55) . Finally, it is worth considering the possibility that neurotransmitters or peptides that elevate intracellular cAMP levels may exert neurotrophic actions on sympathetic or sensory neurons.
Our observations may also prove useful for illuminating the molecular events involved in neurotrophic factor action. A common property of NGF and cAMP analogs is the induction of rapid changes in the phosphorylation of specific cellular proteins (14, 15) . This suggests that protein phosphorylation may play a causative role in both neuronal survival and neurite outgrowth and that comparison of the phosphorylations evoked by NGF and cAMP analogs will be relevant to understanding the similarities and differences in responses to these agents. Also, since the cAMP analogs discussed here permit otherwise NGF-requiring neurons to be cultured without the factor, it will be possible to examine the primary events that occur after exposure to NGF.
Finally, the present findings may have clinical relevance. By promoting survival, differentiation and/or regeneration, these analogs have potential use for treating injuries or diseases affecting mammalian sympathetic, sensory, and possibly other neurons.
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